BOSTON SCIENTIFIC CORP — Director's Dealing 2013

Aug 16, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2013-08-14

Reporting Person: Ballinger Kevin J. (SVP & Pres, Interven Cardio)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-08-14	Common Stock	S	38171	$11.2816	Disposed	73519	Direct

Footnotes

F1: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.28 to $11.285 per share. The reporting person undertakes to provide, upon request by an appropriate entity or person, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).

F2: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.